DYN
Companies
NASDAQ
Dyne Therapeutics Inc.
Health Care
$10.42
-$13.14 (-55.77%)
Price Chart
Overview
About DYN
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.
Market Cap
$3.1B
Volume
39.3M
Avg. Volume
30.8M
P/E Ratio
-3.7436707
Dividend Yield
0.00%
Employees
138.0
Company Information
Latest News for DYN
Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks
March 12, 2025
Up 165% This Year Will Dyne Therapeutics Continue Its Stellar Run?
May 22, 2024
After Plunging -10.43% in 4 Weeks, Here's Why the Trend Might Reverse for Dyne Therapeutics (DYN)
February 13, 2025
Risk & Correlation Analysis
Market Correlation
1.06
Moderate Correlation
Volatility
High (0.80)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, DYN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025